Emilie Laprévotte

Inhibition of CD39 Enzymatic Function at the Surface of Tumor Cells Alleviates Their Immunosuppressive Activity

Jérémy Bastid, Anne Regairaz, Nathalie Bonnefoy et al. · Cancer Immunology Research · 2014 · 250 citations

Medicine, Immunology, Oncology +17

IL-17A is produced by breast cancer TILs and promotes chemoresistance and proliferation through ERK1/2

Stéphanie Cochaud, Jérôme Giustiniani, Clémence Thomas et al. · Scientific Reports · 2013 · 146 citations · Full text

Medicine, Immunology, Oncology +17

Specific small nucleolar RNA expression profiles in acute leukemia

Wilfried Valleron, Emilie Laprévotte, Emilie‐Fleur Gautier et al. · Leukemia · 2012 · 124 citations

Life Sciences, Molecular Biology, Oncology +12

IL-17A and its homologs IL-25/IL-17E recruit the c-RAF/S6 kinase pathway and the generation of pro-oncogenic LMW-E in breast cancer cells

Sarah Mombelli, Stéphanie Cochaud, Yacine Merrouche et al. · Scientific Reports · 2015 · 56 citations · Full text

Life Sciences, Immunology, Oncology +17

The IL-17B-IL-17 receptor B pathway promotes resistance to paclitaxel in breast tumors through activation of the ERK1/2 pathway

Emilie Laprévotte, Stéphanie Cochaud, Stanislas du Manoir et al. · Oncotarget · 2017 · 52 citations · Full text

Life Sciences, Immunology, Oncology +16